Skip to main content

Introduction to a review series on new therapeutics for inherited and acquired bleeding conditions.

Publication ,  Journal Article
Ortel, TL
Published in: Blood
January 31, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

January 31, 2019

Volume

133

Issue

5

Start / End Page

383 / 384

Location

United States

Related Subject Headings

  • Immunology
  • Humans
  • Hemorrhagic Disorders
  • Blood Coagulation Disorders
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ortel, T. L. (2019). Introduction to a review series on new therapeutics for inherited and acquired bleeding conditions. Blood, 133(5), 383–384. https://doi.org/10.1182/blood-2018-12-877779
Ortel, Thomas L. “Introduction to a review series on new therapeutics for inherited and acquired bleeding conditions.Blood 133, no. 5 (January 31, 2019): 383–84. https://doi.org/10.1182/blood-2018-12-877779.
Ortel, Thomas L. “Introduction to a review series on new therapeutics for inherited and acquired bleeding conditions.Blood, vol. 133, no. 5, Jan. 2019, pp. 383–84. Pubmed, doi:10.1182/blood-2018-12-877779.

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

January 31, 2019

Volume

133

Issue

5

Start / End Page

383 / 384

Location

United States

Related Subject Headings

  • Immunology
  • Humans
  • Hemorrhagic Disorders
  • Blood Coagulation Disorders
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology